NCEH1


Description

The NCEH1 (neutral cholesterol ester hydrolase 1) is a protein-coding gene located on chromosome 3.

Neutral cholesterol ester hydrolase 1 (NCEH), also known as arylacetamide deacetylase-like 1 (AADACL1) or KIAA1363, is an enzyme encoded by the NCEH1 gene. Located in the endoplasmic reticulum, NCEH hydrolyzes 2-acetyl monoalkylglycerol ether, a step in the pathway regulating platelet activating factor and lysophospholipids, potentially involved in cancer development. NCEH converts 2-acetyl monoalkylglycerol ether to monoalkylglycerol ether, which can then be transformed into alkyl-lysophosphatidic acid (alkyl-LPA) and alkyl-lysophosphatidylcholine (alkyl-LPC). While some studies suggest NCEH hydrolyzes cholesterol esters, loss of NCEH in mice primarily affects 2-acetyl monoalkylglycerol ether activity. NCEH plays a role in cancer, with cancer cell lines exhibiting high NCEH levels. Reducing NCEH1 in cancer cells decreases tumor migration and growth in mice, while adding alkyl-LPA reverses this effect. NCEH can also degrade organophosphates like chlorpyrifos oxon.

NCEH1 is also known as AADACL1, NCEH.

Associated Diseases



Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.